CDC: A Paxlovid rebound may be ‘natural’ part of a COVID-19 infection By: MarketWatch May 25, 2022 at 10:45 AM EDT The public-health agency continues to recommend the antiviral. Read More >> Related Stocks: Merck & Co Pfizer